Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Collins

Showing results (891-900 of 917) with videos related to

Pageof 92
Sort By:
AIDS Research and Human Retroviruses|July 3, 2024
Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. SouthGrace C Haser, Laurence Balter, Stephen Gurley, et al.
The Journal of Biological Chemistry|October 26, 2017
Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factorAli A Al-Hashimi, Paul Lebeau, Fadwa Majeed, et al.
Journal of the International AIDS Society|February 13, 2026
Optimizing the patient journey: Insights from early implementation of long-acting cabotegravir and rilpivirine in four urban Ryan White-funded clinics in the United StatesXavier A Erguera, Mollie B Smith, Priyasha Pareek, et al.
AIDS and Behavior|January 10, 2026
Social and Healthcare Disruptions Due to the COVID-19 Pandemic and Associations with Psychosocial Well-Being Among Cancer Survivors With and Without HIV: Findings from the MACS/WIHS Combined Cohort StudyOmar Garcia Rodriguez, Yu Chen Lin, Christian Landon, et al.
Journal of the International AIDS Society|November 21, 2024
Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir/rilpivirine among early adopters in three U.S. clinicsKaterina A Christopoulos, Mollie B Smith, Priyasha Pareek, et al.
Pharmacotherapy|July 15, 2024
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases PharmacistsElizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, et al.
Pharmacotherapy|July 15, 2024
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summaryElizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, et al.
Archives of Internal Medicine|June 13, 1998
Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressureW C Cushman, J A Cutler, E Hanna, et al.
Diabetes Care|June 6, 1998
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) StudyT Valle, J Tuomilehto, R N Bergman, et al.
Science (New York, N.Y.)|October 26, 1999
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACER Vassar, B D Bennett, S Babu-Khan, et al.
Pageof 92

Showing results (891-900 of 917) with videos related to

Sort By:
Pageof 92
AIDS Research and Human Retroviruses|July 3, 2024
Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. SouthGrace C Haser, Laurence Balter, Stephen Gurley, et al.
The Journal of Biological Chemistry|October 26, 2017
Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factorAli A Al-Hashimi, Paul Lebeau, Fadwa Majeed, et al.
Journal of the International AIDS Society|February 13, 2026
Optimizing the patient journey: Insights from early implementation of long-acting cabotegravir and rilpivirine in four urban Ryan White-funded clinics in the United StatesXavier A Erguera, Mollie B Smith, Priyasha Pareek, et al.
AIDS and Behavior|January 10, 2026
Social and Healthcare Disruptions Due to the COVID-19 Pandemic and Associations with Psychosocial Well-Being Among Cancer Survivors With and Without HIV: Findings from the MACS/WIHS Combined Cohort StudyOmar Garcia Rodriguez, Yu Chen Lin, Christian Landon, et al.
Journal of the International AIDS Society|November 21, 2024
Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir/rilpivirine among early adopters in three U.S. clinicsKaterina A Christopoulos, Mollie B Smith, Priyasha Pareek, et al.
Pharmacotherapy|July 15, 2024
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases PharmacistsElizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, et al.
Pharmacotherapy|July 15, 2024
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summaryElizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, et al.
Archives of Internal Medicine|June 13, 1998
Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressureW C Cushman, J A Cutler, E Hanna, et al.
Diabetes Care|June 6, 1998
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) StudyT Valle, J Tuomilehto, R N Bergman, et al.
Science (New York, N.Y.)|October 26, 1999
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACER Vassar, B D Bennett, S Babu-Khan, et al.
Pageof 92